Promising drug targets and associated therapeutic interventions in Parkinson’s disease

Promising drug targets and associated therapeutic interventions in Parkinson’s disease

Parkinson’s disease (PD) is one of the most debilitating brain diseases. Despite the availability of symptomatic treatments, response towards the health of PD patients remains scarce. To fulfil the medical needs of the PD patients, an efficacious and etiological treatment is required. In this review...

Full description

Bibliographic Details
Main Authors: Sachchida Nand Rai, Payal Singh, Ritu Varshney, Vivek K Chaturvedi, Emanuel Vamanu, M P Singh, Brijesh Kumar Singh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Neural Regeneration Research
Subjects:
dopamine; epigenetics; gene therapies; glutamate receptor; levodopa; molecular chaperones; monoamine oxidase b; mucuna alpha-synuclein; parkinson’s disease; striatum; substantia nigra
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=9;spage=1730;epage=1739;aulast=Rai
Description
Summary:Parkinson’s disease (PD) is one of the most debilitating brain diseases. Despite the availability of symptomatic treatments, response towards the health of PD patients remains scarce. To fulfil the medical needs of the PD patients, an efficacious and etiological treatment is required. In this review, we have compiled the information covering limitations of current therapeutic options in PD, novel drug targets for PD, and finally, the role of some critical beneficial natural products to control the progression of PD.
ISSN:1673-5374

Similar Items